Therese K Killeen

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
539N
67 President St.
Phone843-792-5232
Fax843-792-7353
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Killeen's general research interests are in the area of effective treatment approaches for substance use disorders (SUD) and comorbidity, with a particular expertise in PTSD and SUD comorbidity. She has lead several large NIDA Clinical Trial Network studies exploring psychosocial therapies in the treatment of substance use and comorbid disorders. She is an expert in motivational interviewing, cognitive behavior and contingency management therapies, and more recently she is involved in research exploring the effectiveness of using mindfulness based relapse prevention in improving substance use outcomes. In her role as dissemination specialist over the past 15 years, she has worked with front line community treatment programs and clinicians to adopt evidence based treatments. She has mentored numerous clinicians both within MUSC and in community practice using evidence based supervision.
    Collapse keywords
    Stress Disorders, Complementary Medicine, Substance Use, addiction treatment, comorbidity, PTSD, dissemination, supervision

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Morgan-L?pez AA, Saavedra LM, Hien DA, Norman SB, Fitzpatrick SS, Ye A, Killeen TK, Ruglass LM, Blakey SM, Back SE. Differential symptom weighting in estimating empirical thresholds for underlying PTSD severity: Toward a "platinum" standard for diagnosis? Int J Methods Psychiatr Res. 2023 Feb 15; e1963. PMID: 36789653.
      Citations:    Fields:    
    2. Killeen TK, Wen CC, Neelon B, Baker N. Predictors of Treatment Completion among Women Receiving Integrated Treatment for Comorbid Posttraumatic Stress and Substance Use Disorders. Subst Use Misuse. 2023; 58(4):500-511. PMID: 36705433.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Ruglass LM, Shevorykin A, Zhao Y, Killeen TK, Bauer AG, Morgan-L?pez AA, Back SE, Fitzpatrick S, L?pez-Castro T, Norman SB, Saavedra LM, Hien DA. Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics. Drug Alcohol Depend. 2023 03 01; 244:109769. PMID: 36696843; PMCID: PMC9987239.
      Citations:    Fields:    Translation:HumansAnimalsPHPublic HealthCTClinical Trials
    4. Back SE, Flanagan JC, Killeen T, Saraiya TC, Brown DG, Jarnecke AM, Rothbaum AO, Joseph J, Ana ES, de Arellano A, Shoemaker HL, Dixon RA, Nietert PJ, Brady KT. COPE and oxytocin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in U.S. military veterans. Contemp Clin Trials. 2023 03; 126:107084. PMID: 36646315; PMCID: PMC9998357.
      Citations:    Fields:    Translation:Humans
    5. Saraiya TC, Jarnecke AM, Bauer A, Brown DG, Killeen T, Back SE. Patient and therapist-rated alliance predict improvements in PTSD symptoms and substance use in an integrated treatment for PTSD and SUD. Clin Psychol Psychother. 2022 Dec 12. PMID: 36509681.
      Citations:    Fields:    Translation:Humans
    6. Hien DA, Morgan-L?pez AA, Saavedra LM, Ruglass LM, Ye A, L?pez-Castro T, Fitzpatrick S, Killeen TK, Norman SB, Ebrahimi CT, Back SE. Project Harmony: A Meta-Analysis With Individual Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic Stress and Alcohol or Other Drug Use Disorders. Am J Psychiatry. 2023 02 01; 180(2):155-166. PMID: 36475373; PMCID: PMC10016363.
      Citations: 1     Fields:    Translation:Humans
    7. Killeen TK, Brewerton TD. Women with PTSD and Substance Use Disorders in a Research Treatment Study: A Comparison of those with and without the Dissociative Subtype of PTSD. J Trauma Dissociation. 2023 Mar-Apr; 24(2):229-240. PMID: 36266949; PMCID: PMC9905299.
      Citations:    Fields:    Translation:Humans
    8. Saavedra LM, Morgan-L?pez AA, Back SE, Patel SV, Hien DA, Killeen TK, Norman SB, Fitzpatrick S, Ebrahimi CT, Ruglass LM. Measurement Error-Corrected Estimation of Clinically Significant Change Trajectories for Interventions Targeting Comorbid PTSD and Substance Use Disorders in OEF/OIF Veterans. Behav Ther. 2022 09; 53(5):1009-1023. PMID: 35987532.
      Citations:    Fields:    Translation:Humans
    9. Jarnecke AM, Saraiya TC, Brown DG, Richardson J, Killeen T, Back SE, Jarnecke AM, Saraiya TC, Brown DG, Richardson J, Killeen T, Back SE. Examining the role of social support in treatment for co-occurring substance use disorder and posttraumatic stress disorder. Addict Behav Rep. 2022 Jun; 15:100427. PMID: 35480064; PMCID: PMC9036141.
      Citations: 1     
    10. Morgan-López AA, Hien DA, Saraiya TC, Saavedra LM, Norman SB, Killeen TK, Simpson TL, Fitzpatrick S, Mills KL, Ruglass LM, Back SE, López-Castro T, Morgan-L?pez AA, Hien DA, Saraiya TC, Saavedra LM, Norman SB, Killeen TK, Simpson TL, Fitzpatrick S, Mills KL, Ruglass LM, Back SE, L?pez-Castro T, Consortium on Addiction, Stress and Trauma (CAST). Estimating posttraumatic stress disorder severity in the presence of differential item functioning across populations, comorbidities, and interview measures: Introduction to Project Harmony. J Trauma Stress. 2022 06; 35(3):926-940. PMID: 35124864; PMCID: PMC9844237.
      Citations:    
    11. Saraiya TC, Badour CL, Jones AC, Jarnecke AM, Brown DG, Flanagan JC, Killeen TK, Back SE, Saraiya TC, Badour CL, Jones AC, Jarnecke AM, Brown DG, Flanagan JC, Killeen TK, Back SE. The role of posttraumatic guilt and anger in integrated treatment for PTSD and co-occurring substance use disorders among primarily male veterans. Psychol Trauma. 2022 Jan 13. PMID: 35025558; PMCID: PMC9276835.
      Citations:    
    12. Hien DA, Fitzpatrick S, Saavedra LM, Ebrahimi CT, Norman SB, Tripp J, Ruglass LM, Lopez-Castro T, Killeen TK, Back SE, Morgan-López AA, Hien DA, Fitzpatrick S, Saavedra LM, Ebrahimi CT, Norman SB, Tripp J, Ruglass LM, Lopez-Castro T, Killeen TK, Back SE, Morgan-L?pez AA. What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders. Eur J Psychotraumatol. 2022; 13(1):2001191. PMID: 34992759; PMCID: PMC8725709.
      Citations:    
    13. Badour CL, Flanagan JC, Allan NP, Gilmore AK, Gros DF, Killeen T, Korte KJ, Brown DG, Kolnogorova K, Back SE, Badour CL, Flanagan JC, Allan NP, Gilmore AK, Gros DF, Killeen T, Korte KJ, Brown DG, Kolnogorova K, Back SE. Temporal dynamics of symptom change among veterans receiving an integrated treatment for posttraumatic stress disorder and substance use disorders. J Trauma Stress. 2022 04; 35(2):546-558. PMID: 34773928; PMCID: PMC9035042.
      Citations:    
    14. Saavedra LM, Morgan-López AA, Hien DA, López-Castro T, Ruglass LM, Back SE, Fitzpatrick S, Norman SB, Killeen TK, Ebrahimi CT, Hamblen J, Saavedra LM, Morgan-L?pez AA, Hien DA, L?pez-Castro T, Ruglass LM, Back SE, Fitzpatrick S, Norman SB, Killeen TK, Ebrahimi CT, Hamblen J, CAST, the Consortium on Addictions, Stress and Trauma. Evaluating treatments for posttraumatic stress disorder, alcohol and other drug use disorders using meta-analysis of individual patient data: Design and methodology of a virtual clinical trial. Contemp Clin Trials. 2021 08; 107:106479. PMID: 34157418.
      Citations:    
    15. Fitzpatrick SS, Morgan-López AA, Saraiya TC, Back SE, Killeen TK, Norman SB, López-Castro T, Ruglass LM, Saavedra LM, Hien DA, Fitzpatrick SS, Morgan-L?pez AA, Saraiya TC, Back SE, Killeen TK, Norman SB, L?pez-Castro T, Ruglass LM, Saavedra LM, Hien DA. Graded response item response theory in scaling suicidal thoughts and behaviors among trauma-exposed women with substance use disorders. Psychol Addict Behav. 2022 Jun; 36(4):397-409. PMID: 34138594; PMCID: PMC8678388.
      Citations:    
    16. Orr RK, Hoehn JL, Col NF, Brady KT, Killeen T, Baker NL. Efficacy of mindfulness-based relapse prevention in veterans with substance use disorders: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2021 06; 105:106393. PMID: 33857680.
      Citations:    
    17. Saavedra LM, Morgan-López AA, Hien DA, Killeen TK, Back SE, Ruglass LM, Fitzpatrick S, Lopez-Castro T, Saavedra LM, Morgan-L?pez AA, Hien DA, Killeen TK, Back SE, Ruglass LM, Fitzpatrick S, Lopez-Castro T. Putting the Patient Back in Clinical Significance: Moderated Nonlinear Factor Analysis for Estimating Clinically Significant Change in Treatment for Posttraumatic Stress Disorder. J Trauma Stress. 2021 04; 34(2):454-466. PMID: 33175470.
      Citations:    
    18. Brown DG, Flanagan JC, Jarnecke A, Killeen TK, Back SE, Brown DG, Flanagan JC, Jarnecke A, Killeen TK, Back SE. Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment. J Ethn Subst Abuse. 2022 Jul-Sep; 21(3):1141-1164. PMID: 33111647; PMCID: PMC8079537.
      Citations:    
    19. Ruglass LM, Morgan-López AA, Saavedra LM, Hien DA, Fitzpatrick S, Killeen TK, Back SE, López-Castro T, Ruglass LM, Morgan-L?pez AA, Saavedra LM, Hien DA, Fitzpatrick S, Killeen TK, Back SE, L?pez-Castro T. Measurement nonequivalence of the Clinician-Administered PTSD Scale by race/ethnicity: Implications for quantifying posttraumatic stress disorder severity. Psychol Assess. 2020 Nov; 32(11):1015-1027. PMID: 32853005; PMCID: PMC8136270.
      Citations:    
    20. Killeen TK, Wolf B, Greer TL, Carmody T, Rethorst CD, Trivedi MH, Killeen TK, Wolf B, Greer TL, Carmody T, Rethorst CD, Trivedi MH. Gender and racial/ethnic differences in physiologic responses in the Stimulant Reduction Intervention using Dosed Exercise Study. Addict Behav. 2020 11; 110:106546. PMID: 32688225; PMCID: PMC7416606.
      Citations:    
    21. Morgan-López AA, Killeen TK, Saavedra LM, Hien DA, Fitzpatrick S, Ruglass LM, Back SE, Morgan-L?pez AA, Killeen TK, Saavedra LM, Hien DA, Fitzpatrick S, Ruglass LM, Back SE. Crossover between diagnostic and empirical categorizations of full and subthreshold PTSD. J Affect Disord. 2020 09 01; 274:832-840. PMID: 32664022; PMCID: PMC7388200.
      Citations:    
    22. Orr RK, Hoehn JL, Col NF, Allan NP, L?pez-Castro T, Hien DA, Papini S, Killeen TK, Gros DF, Ruglass LM, Barrett E, Back SE. Response-to-Treatment for Comorbid Post-Traumatic Stress and Substance Use Disorders: The Value of Combining Person- and Variable-Centered Approaches. J Psychopathol Behav Assess. 2020 Dec; 42(4):725-738. PMID: 33239837; PMCID: PMC7682732.
      Citations:    
    23. Hien D, Kropp F, Wells EA, Campbell A, Hatch-Maillette M, Hodgkins C, Killeen T, Lopez-Castro T, Morgan-Lopez A, Ruglass LM, Saavedra L, Nunes EV, Hien D, Kropp F, Wells EA, Campbell A, Hatch-Maillette M, Hodgkins C, Killeen T, Lopez-Castro T, Morgan-Lopez A, Ruglass LM, Saavedra L, Nunes EV. The "Women and Trauma" study and its national impact on advancing trauma specific approaches in community substance use treatment and research. J Subst Abuse Treat. 2020 03; 112S:12-17. PMID: 32220405; PMCID: PMC7123457.
      Citations:    
    24. Back SE, Gray K, Santa Ana E, Jones JL, Jarnecke AM, Joseph JE, Prisciandaro J, Killeen T, Brown DG, Taimina L, Compean E, Malcolm R, Flanagan JC, Kalivas PW, Back SE, Gray K, Santa Ana E, Jones JL, Jarnecke AM, Joseph JE, Prisciandaro J, Killeen T, Brown DG, Taimina L, Compean E, Malcolm R, Flanagan JC, Kalivas PW. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961. PMID: 32087337; PMCID: PMC7333883.
      Citations:    
    25. Morgan-López AA, Saavedra LM, Hien DA, Killeen TK, Back SE, Ruglass LM, Fitzpatrick S, López-Castro T, Patock-Peckham JA, Morgan-L?pez AA, Saavedra LM, Hien DA, Killeen TK, Back SE, Ruglass LM, Fitzpatrick S, L?pez-Castro T, Patock-Peckham JA. Estimation of equable scale scores and treatment outcomes from patient- and clinician-reported PTSD measures using item response theory calibration. Psychol Assess. 2020 Apr; 32(4):321-335. PMID: 31804102.
      Citations:    
    26. Moreland A, McCauley J, Barth K, Bogdon C, Killeen T, Haynes L, Jennings L, Guille C, Goldsby S, Brady K, Moreland A, McCauley J, Barth K, Bogdon C, Killeen T, Haynes L, Jennings L, Guille C, Goldsby S, Brady K. Assessing the needs of front-line providers in addressing the opioid crisis in South Carolina. J Subst Abuse Treat. 2020 01; 108:4-8. PMID: 31303360; PMCID: PMC6893121.
      Citations:    
    27. Lancaster CL, Gros DF, Mullarkey MC, Badour CL, Killeen TK, Brady KT, Back SE, Lancaster CL, Gros DF, Mullarkey MC, Badour CL, Killeen TK, Brady KT, Back SE. Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders? Behav Cogn Psychother. 2020 Jan; 48(1):38-53. PMID: 31010449; PMCID: PMC6832765.
      Citations:    
    28. Jeffirs SM, Jarnecke AM, Flanagan JC, Killeen TK, Laffey TF, Back SE, Jeffirs SM, Jarnecke AM, Flanagan JC, Killeen TK, Laffey TF, Back SE. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes? Drug Alcohol Depend. 2019 06 01; 199:70-75. PMID: 31009834; PMCID: PMC6534455.
      Citations:    
    29. Szafranski DD, Gros DF, Acierno R, Brady KT, Killeen TK, Back SE, Szafranski DD, Gros DF, Acierno R, Brady KT, Killeen TK, Back SE. Heterogeneity of treatment dropout: PTSD, depression, and alcohol use disorder reductions in PTSD and AUD/SUD treatment noncompleters. Clin Psychol Psychother. 2019 Mar; 26(2):218-226. PMID: 30419153.
      Citations:    
    30. Back SE, Killeen T, Badour CL, Flanagan JC, Allan NP, Ana ES, Lozano B, Korte KJ, Foa EB, Brady KT, Back SE, Killeen T, Badour CL, Flanagan JC, Allan NP, Ana ES, Lozano B, Korte KJ, Foa EB, Brady KT. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans. Addict Behav. 2019 03; 90:369-377. PMID: 30529244; PMCID: PMC6488423.
      Citations:    
    31. Jarnecke AM, Allan NP, Badour CL, Flanagan JC, Killeen TK, Back SE, Jarnecke AM, Allan NP, Badour CL, Flanagan JC, Killeen TK, Back SE. Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure. Addict Behav. 2019 03; 90:35-39. PMID: 30355535; PMCID: PMC6324999.
      Citations:    
    32. Hu L, Matthews A, Shmueli-Blumberg D, Killeen TK, Tai B, VanVeldhuisen P, Hu L, Matthews A, Shmueli-Blumberg D, Killeen TK, Tai B, VanVeldhuisen P. Prevalence of obesity for opioid- and stimulant-dependent participants in substance use treatment clinical trials. Drug Alcohol Depend. 2018 09 01; 190:255-262. PMID: 30077926.
      Citations:    
    33. Spratt ES, Papa CE, Mueller M, Patel S, Killeen T, Maher E, Drayton C, Dixon TC, Fowler SL, Treiber F, Spratt ES, Papa CE, Mueller M, Patel S, Killeen T, Maher E, Drayton C, Dixon TC, Fowler SL, Treiber F. Using Technology to Improve Adherence to HIV Medications in Transitional Age Youth: Research Reviewed, Methods Tried, Lessons Learned. J Gen Med (Dover). 2017; 1(1). PMID: 30345429; PMCID: PMC6195351.
      Citations:    
    34. Vrana C, Killeen T, Brant V, Mastrogiovanni J, Baker NL, Vrana C, Killeen T, Brant V, Mastrogiovanni J, Baker NL. Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder. Contemp Clin Trials. 2017 10; 61:108-114. PMID: 28765006; PMCID: PMC5581670.
      Citations:    
    35. Flanagan JC, Fischer MS, Badour CL, Ornan G, Killeen TK, Back SE, Flanagan JC, Fischer MS, Badour CL, Ornan G, Killeen TK, Back SE. The Role of Relationship Adjustment in an Integrated Individual Treatment for PTSD and Substance Use Disorders Among Veterans: An Exploratory Study. J Dual Diagn. 2017 Jul-Sep; 13(3):213-218. PMID: 28541802; PMCID: PMC5544565.
      Citations:    
    36. Ruglass LM, Lopez-Castro T, Papini S, Killeen T, Back SE, Hien DA, Ruglass LM, Lopez-Castro T, Papini S, Killeen T, Back SE, Hien DA. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial. Psychother Psychosom. 2017; 86(3):150-161. PMID: 28490022; PMCID: PMC5610572.
      Citations:    
    37. Szafranski DD, Snead A, Allan NP, Gros DF, Killeen T, Flanagan J, Pericot-Valverde I, Back SE, Szafranski DD, Snead A, Allan NP, Gros DF, Killeen T, Flanagan J, Pericot-Valverde I, Back SE. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout. Addict Behav. 2017 10; 73:30-35. PMID: 28460246; PMCID: PMC5507590.
      Citations:    
    38. Mills AC, Badour CL, Korte KJ, Killeen TK, Henschel AV, Back SE, Mills AC, Badour CL, Korte KJ, Killeen TK, Henschel AV, Back SE. Integrated Treatment of PTSD and Substance Use Disorders: Examination of Imaginal Exposure Length. J Trauma Stress. 2017 04; 30(2):166-172. PMID: 28329434; PMCID: PMC5507581.
      Citations:    
    39. Persson A, Back SE, Killeen TK, Brady KT, Schwandt ML, Heilig M, Magnusson Å, Persson A, Back SE, Killeen TK, Brady KT, Schwandt ML, Heilig M, Magnusson ?. Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE): A Pilot Study in Alcohol-dependent Women. J Addict Med. 2017 Mar/Apr; 11(2):119-125. PMID: 28079572; PMCID: PMC6223130.
      Citations:    
    40. Badour CL, Flanagan JC, Gros DF, Killeen T, Pericot-Valverde I, Korte KJ, Allan NP, Back SE, Badour CL, Flanagan JC, Gros DF, Killeen T, Pericot-Valverde I, Korte KJ, Allan NP, Back SE. Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity. J Consult Clin Psychol. 2017 Mar; 85(3):274-281. PMID: 28221062; PMCID: PMC5328591.
      Citations:    
    41. Sherman BJ, McRae-Clark AL, Baker NL, Sonne SC, Killeen TK, Cloud K, Gray KM, Sherman BJ, McRae-Clark AL, Baker NL, Sonne SC, Killeen TK, Cloud K, Gray KM. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017 Mar; 26(2):136-144. PMID: 28152236; PMCID: PMC5323358.
      Citations:    
    42. Jaconis M, Santa Ana EJ, Killeen TK, Badour CL, Back SE, Jaconis M, Santa Ana EJ, Killeen TK, Badour CL, Back SE. Concurrent treatment of PTSD and alcohol use disorder via telehealth in a female Iraq veteran. Am J Addict. 2017 Mar; 26(2):112-114. PMID: 28118514; PMCID: PMC5527553.
      Citations:    
    43. Korte KJ, Bountress KE, Tomko RL, Killeen T, Moran-Santa Maria M, Back SE, Korte KJ, Bountress KE, Tomko RL, Killeen T, Moran-Santa Maria M, Back SE. Integrated Treatment of PTSD and Substance Use Disorders: The Mediating Role of PTSD Improvement in the Reduction of Depression. J Clin Med. 2017 Jan 13; 6(1). PMID: 28098747; PMCID: PMC5294962.
      Citations:    
    44. Merghati-Khoei ES, Rezaei Z, Shojaei-Zadeh D, Azadi NA, Rimaz S, Bayat A, Moayedi-Nia S, Omati S, Salimi F, Korte J, Killeen T, Mohraz M, Merghati-Khoei ES, Rezaei Z, Shojaei-Zadeh D, Azadi NA, Rimaz S, Bayat A, Moayedi-Nia S, Omati S, Salimi F, Korte J, Killeen T, Mohraz M. Sexual Risk Behaviors and Condom Use Barriers in Iranian Men with Substance Use Disorders. Addict Health. 2017 Jan; 9(1):40-47. PMID: 29026502; PMCID: PMC5628767.
      Citations:    
    45. Flanagan JC, Korte KJ, Killeen TK, Back SE, Flanagan JC, Korte KJ, Killeen TK, Back SE. Concurrent Treatment of Substance Use and PTSD. Curr Psychiatry Rep. 2016 08; 18(8):70. PMID: 27278509; PMCID: PMC4928573.
      Citations:    
    46. Hatch-Maillette M, Wells EA, Doyle SR, Brigham GS, Daley D, DiCenzo J, Donovan D, Garrett S, Horigian VE, Jenkins L, Killeen T, Owens M, Perl HI, Hatch-Maillette M, Wells EA, Doyle SR, Brigham GS, Daley D, DiCenzo J, Donovan D, Garrett S, Horigian VE, Jenkins L, Killeen T, Owens M, Perl HI. Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders. J Subst Abuse Treat. 2016 09; 68:74-82. PMID: 27431050; PMCID: PMC5462490.
      Citations:    
    47. Adams ZW, McCauley JL, Back SE, Flanagan JC, Hanson RF, Killeen TK, Danielson CK, Adams ZW, McCauley JL, Back SE, Flanagan JC, Hanson RF, Killeen TK, Danielson CK. Clinician Perspectives on Treating Adolescents with Co-occurring Post-Traumatic Stress Disorder, Substance Use, and Other Problems. J Child Adolesc Subst Abuse. 2016; 25(6):575-583. PMID: 27840568; PMCID: PMC5100692.
      Citations:    
    48. Marriott BP, Hibbeln JR, Killeen TK, Magruder KM, Holes-Lewis K, Tolliver BK, Turner TH, Marriott BP, Hibbeln JR, Killeen TK, Magruder KM, Holes-Lewis K, Tolliver BK, Turner TH, BRAVO Group. Design and methods for the Better Resiliency Among Veterans and non-Veterans with Omega-3's (BRAVO) study: A double blind, placebo-controlled trial of omega-3 fatty acid supplementation among adult individuals at risk of suicide. Contemp Clin Trials. 2016 Mar; 47:325-33. PMID: 26855120.
      Citations:    
    49. McRae-Clark AL, Baker NL, Gray KM, Killeen T, Hartwell KJ, Simonian SJ, McRae-Clark AL, Baker NL, Gray KM, Killeen T, Hartwell KJ, Simonian SJ. Vilazodone for cannabis dependence: A randomized, controlled pilot trial. Am J Addict. 2016 Jan; 25(1):69-75. PMID: 26685701; PMCID: PMC4937726.
      Citations:    
    50. Wu LT, Brady KT, Spratt SE, Dunham AA, Heidenfelder B, Batch BC, Lindblad R, VanVeldhuisen P, Rusincovitch SA, Killeen TK, Ghitza UE, Wu LT, Brady KT, Spratt SE, Dunham AA, Heidenfelder B, Batch BC, Lindblad R, VanVeldhuisen P, Rusincovitch SA, Killeen TK, Ghitza UE. Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study. Contemp Clin Trials. 2016 Jan; 46:30-38. PMID: 26563446; PMCID: PMC4695300.
      Citations:    
    51. Killeen T, Brewerton TD, Campbell A, Cohen LR, Hien DA, Killeen T, Brewerton TD, Campbell A, Cohen LR, Hien DA. Exploring the relationship between eating disorder symptoms and substance use severity in women with comorbid PTSD and substance use disorders. Am J Drug Alcohol Abuse. 2015; 41(6):547-52. PMID: 26366716; PMCID: PMC4689437.
      Citations:    
    52. McRae-Clark AL, Baker NL, Gray KM, Killeen TK, Wagner AM, Brady KT, DeVane CL, Norton J, McRae-Clark AL, Baker NL, Gray KM, Killeen TK, Wagner AM, Brady KT, DeVane CL, Norton J. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug Alcohol Depend. 2015 Nov 01; 156:29-37. PMID: 26386827; PMCID: PMC4633378.
      Citations:    
    53. Lozano BE, Gros DF, Killeen T, Jaconis M, Beylotte FM, Boyd S, Back SE, Lozano BE, Gros DF, Killeen T, Jaconis M, Beylotte FM, Boyd S, Back SE. To reduce or abstain? Substance use goals in the treatment of veterans with substance use disorders and comorbid PTSD. Am J Addict. 2015 Oct; 24(7):578-81. PMID: 26300219; PMCID: PMC4867466.
      Citations:    
    54. Jobe-Shields L, Flanagan JC, Killeen T, Back SE, Jobe-Shields L, Flanagan JC, Killeen T, Back SE. Family composition and symptom severity among Veterans with comorbid PTSD and substance use disorders. Addict Behav. 2015 Nov; 50:117-23. PMID: 26132535; PMCID: PMC4570495.
      Citations:    
    55. Killeen TK, Back SE, Brady KT, Killeen TK, Back SE, Brady KT. Implementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs. Drug Alcohol Rev. 2015 May; 34(3):234-41. PMID: 25737377; PMCID: PMC4737595.
      Citations:    
    56. Chartier KG, Sanchez K, Killeen TK, Burrow A, Carmody T, Greer TL, Trivedi MH, Chartier KG, Sanchez K, Killeen TK, Burrow A, Carmody T, Greer TL, Trivedi MH. Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry. Am J Addict. 2015 Jun; 24(4):336-40. PMID: 25694201; PMCID: PMC4803500.
      Citations:    
    57. Flanagan JC, Teer A, Beylotte FM, Killeen TK, Back SE, Flanagan JC, Teer A, Beylotte FM, Killeen TK, Back SE. Correlates of Recent and Lifetime Aggression among Veterans with Co-Occurring PTSD and Substance Use Disorders. Ment Health Subst Use. 2014; 7(4):315-328. PMID: 25419233; PMCID: PMC4240275.
      Citations:    
    58. Merghati-Khoei E, Sheikhan F, Shamsalizadeh N, Haghani H, Yousofnia Pasha YR, Killeen T, Merghati-Khoei E, Sheikhan F, Shamsalizadeh N, Haghani H, Yousofnia Pasha YR, Killeen T. Menopause negatively impacts sexual lives of middle-aged Iranian women: a cross-sectional study. J Sex Marital Ther. 2014; 40(6):552-60. PMID: 24308863.
      Citations:    
    59. Wu LT, Brady KT, Mannelli P, Killeen TK, Wu LT, Brady KT, Mannelli P, Killeen TK, NIDA?AAPI?Workgroup. Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study. J Psychiatr Res. 2014 Mar; 50:26-35. PMID: 24342767; PMCID: PMC3941308.
      Citations:    
    60. Back SE, Killeen TK, Teer AP, Hartwell EE, Federline A, Beylotte F, Cox E, Back SE, Killeen TK, Teer AP, Hartwell EE, Federline A, Beylotte F, Cox E. Substance use disorders and PTSD: an exploratory study of treatment preferences among military veterans. Addict Behav. 2014 Feb; 39(2):369-73. PMID: 24199930; PMCID: PMC3855915.
      Citations:    
    61. Brady KT, Haynes LF, Hartwell KJ, Killeen TK, Brady KT, Haynes LF, Hartwell KJ, Killeen TK. Substance use disorders and anxiety: a treatment challenge for social workers. Soc Work Public Health. 2013; 28(3-4):407-23. PMID: 23731428; PMCID: PMC3775646.
      Citations:    
    62. McCauley JL, Killeen T, Gros DF, Brady KT, Back SE, McCauley JL, Killeen T, Gros DF, Brady KT, Back SE. Posttraumatic Stress Disorder and Co-Occurring Substance Use Disorders: Advances in Assessment and Treatment. Clin Psychol (New York). 2012 Sep 01; 19(3). PMID: 24179316; PMCID: PMC3811127.
      Citations:    
    63. Back SE, Killeen T, Foa EB, Santa Ana EJ, Gros DF, Brady KT, Back SE, Killeen T, Foa EB, Santa Ana EJ, Gros DF, Brady KT. Use of an integrated therapy with prolonged exposure to treat PTSD and comorbid alcohol dependence in an Iraq veteran. Am J Psychiatry. 2012 Jul; 169(7):688-91. PMID: 22760188; PMCID: PMC3654811.
      Citations:    
    64. Donovan DM, Daley DC, Brigham GS, Hodgkins CC, Perl HI, Garrett SB, Doyle SR, Floyd AS, Knox PC, Botero C, Kelly TM, Killeen TK, Hayes C, Kau'i Baumhofer N, Kau'ibaumhofer N, Seamans C, Zammarelli L, Donovan DM, Daley DC, Brigham GS, Hodgkins CC, Perl HI, Garrett SB, Doyle SR, Floyd AS, Knox PC, Botero C, Kelly TM, Killeen TK, Hayes C, Kau'i Baumhofer N, Kau'ibaumhofer N, Seamans C, Zammarelli L. Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network. J Subst Abuse Treat. 2013 Jan; 44(1):103-14. PMID: 22657748; PMCID: PMC3434261.
      Citations:    
    65. Ruglass LM, Miele GM, Hien DA, Campbell AN, Hu MC, Caldeira N, Jiang H, Litt L, Killeen T, Hatch-Maillette M, Najavits L, Brown C, Robinson JA, Brigham GS, Nunes EV, Ruglass LM, Miele GM, Hien DA, Campbell AN, Hu MC, Caldeira N, Jiang H, Litt L, Killeen T, Hatch-Maillette M, Najavits L, Brown C, Robinson JA, Brigham GS, Nunes EV. Helping alliance, retention, and treatment outcomes: a secondary analysis from the NIDA Clinical Trials Network Women and Trauma Study. Subst Use Misuse. 2012 May; 47(6):695-707. PMID: 22475068; PMCID: PMC3639137.
      Citations:    
    66. Killeen TK, McRae-Clark AL, Waldrop AE, Upadhyaya H, Brady KT, Killeen TK, McRae-Clark AL, Waldrop AE, Upadhyaya H, Brady KT. Contingency management in community programs treating adolescent substance abuse: a feasibility study. J Child Adolesc Psychiatr Nurs. 2012 Feb; 25(1):33-41. PMID: 22299805; PMCID: PMC3322112.
      Citations:    
    67. Killeen TK, Back SE, Brady KT, Killeen TK, Back SE, Brady KT. The Use of Exposure-Based Treatment Among Individuals With PTSD and Co-occurring Substance Use Disorders: Clinical Considerations. J Dual Diagn. 2011 Oct 01; 7(4):194-206. PMID: 23662094; PMCID: PMC3646384.
      Citations:    
    68. Korte JE, Magruder KM, Chiuzan CC, Logan SL, Killeen T, Bandyopadhyay D, Brady KT, Korte JE, Magruder KM, Chiuzan CC, Logan SL, Killeen T, Bandyopadhyay D, Brady KT. Assessing drug use during follow-up: direct comparison of candidate outcome definitions in pooled analyses of addiction treatment studies. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):358-66. PMID: 21854278; PMCID: PMC3164549.
      Citations:    
    69. Greenfield SF, Rosa C, Putnins SI, Green CA, Brooks AJ, Calsyn DA, Cohen LR, Erickson S, Gordon SM, Haynes L, Killeen T, Miele G, Tross S, Winhusen T, Greenfield SF, Rosa C, Putnins SI, Green CA, Brooks AJ, Calsyn DA, Cohen LR, Erickson S, Gordon SM, Haynes L, Killeen T, Miele G, Tross S, Winhusen T. Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):301-12. PMID: 21854272; PMCID: PMC3160726.
      Citations:    
    70. Svikis DS, Keyser-Marcus L, Stitzer M, Rieckmann T, Safford L, Loeb P, Allen T, Luna-Anderson C, Back SE, Cohen J, DeBernardi MA, Dillard B, Forcehimes A, Jaffee W, Killeen T, Kolodner K, Levy M, Pallas D, Perl HI, Potter JS, Provost S, Reese K, Sampson RR, Sepulveda A, Snead N, Wong CJ, Zweben J, Svikis DS, Keyser-Marcus L, Stitzer M, Rieckmann T, Safford L, Loeb P, Allen T, Luna-Anderson C, Back SE, Cohen J, DeBernardi MA, Dillard B, Forcehimes A, Jaffee W, Killeen T, Kolodner K, Levy M, Pallas D, Perl HI, Potter JS, Provost S, Reese K, Sampson RR, Sepulveda A, Snead N, Wong CJ, Zweben J. Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):55-64. PMID: 21802222; PMCID: PMC3579551.
      Citations:    
    71. Killeen TK, Greenfield SF, Bride BE, Cohen L, Gordon SM, Roman PM, Killeen TK, Greenfield SF, Bride BE, Cohen L, Gordon SM, Roman PM. Assessment and treatment of co-occurring eating disorders in privately funded addiction treatment programs. Am J Addict. 2011 May-Jun; 20(3):205-11. PMID: 21477048; PMCID: PMC3076120.
      Citations:    
    72. McRae-Clark AL, Carter RE, Killeen TK, Carpenter MJ, White KG, Brady KT, McRae-Clark AL, Carter RE, Killeen TK, Carpenter MJ, White KG, Brady KT. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9. PMID: 20958842; PMCID: PMC3019094.
      Citations:    
    73. Hien DA, Campbell AN, Ruglass LM, Hu MC, Killeen T, Hien DA, Campbell AN, Ruglass LM, Hu MC, Killeen T. The role of alcohol misuse in PTSD outcomes for women in community treatment: a secondary analysis of NIDA's Women and Trauma Study. Drug Alcohol Depend. 2010 Sep 01; 111(1-2):114-9. PMID: 20537811; PMCID: PMC2981092.
      Citations:    
    74. Cohen LR, Greenfield SF, Gordon S, Killeen T, Jiang H, Zhang Y, Hien D, Cohen LR, Greenfield SF, Gordon S, Killeen T, Jiang H, Zhang Y, Hien D. Survey of eating disorder symptoms among women in treatment for substance abuse. Am J Addict. 2010 May-Jun; 19(3):245-51. PMID: 20525031; PMCID: PMC2882625.
      Citations:    
    75. McRae-Clark AL, Carter RE, Killeen TK, Carpenter MJ, Wahlquist AE, Simpson SA, Brady KT, McRae-Clark AL, Carter RE, Killeen TK, Carpenter MJ, Wahlquist AE, Simpson SA, Brady KT. A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):132-8. PMID: 19699593; PMCID: PMC2789590.
      Citations:    
    76. Hien DA, Wells EA, Jiang H, Suarez-Morales L, Campbell AN, Cohen LR, Miele GM, Killeen T, Brigham GS, Zhang Y, Hansen C, Hodgkins C, Hatch-Maillette M, Brown C, Kulaga A, Kristman-Valente A, Chu M, Sage R, Robinson JA, Liu D, Nunes EV, Hien DA, Wells EA, Jiang H, Suarez-Morales L, Campbell AN, Cohen LR, Miele GM, Killeen T, Brigham GS, Zhang Y, Hansen C, Hodgkins C, Hatch-Maillette M, Brown C, Kulaga A, Kristman-Valente A, Chu M, Sage R, Robinson JA, Liu D, Nunes EV. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug; 77(4):607-19. PMID: 19634955; PMCID: PMC2795638.
      Citations:    
    77. Hien DA, Campbell AN, Killeen T, Hu MC, Hansen C, Jiang H, Hatch-Maillette M, Miele GM, Cohen LR, Gan W, Resko SM, DiBono M, Wells EA, Nunes EV, Hien DA, Campbell AN, Killeen T, Hu MC, Hansen C, Jiang H, Hatch-Maillette M, Miele GM, Cohen LR, Gan W, Resko SM, DiBono M, Wells EA, Nunes EV. The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA Clinical Trials Network "Women and trauma" multi-site study. AIDS Behav. 2010 Apr; 14(2):421-30. PMID: 19452271; PMCID: PMC2835800.
      Citations:    
    78. Gordon SM, Johnson JA, Greenfield SF, Cohen L, Killeen T, Roman PM, Gordon SM, Johnson JA, Greenfield SF, Cohen L, Killeen T, Roman PM. Assessment and treatment of co-occurring eating disorders in publicly funded addiction treatment programs. Psychiatr Serv. 2008 Sep; 59(9):1056-9. PMID: 18757602; PMCID: PMC3417144.
      Citations:    
    79. Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH, Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry. 2008 Apr; 69(4):520-5. PMID: 18278987.
      Citations:    
    80. Killeen T, Hien D, Campbell A, Brown C, Hansen C, Jiang H, Kristman-Valente A, Neuenfeldt C, Rocz-de la Luz N, Sampson R, Suarez-Morales L, Wells E, Brigham G, Nunes E, Killeen T, Hien D, Campbell A, Brown C, Hansen C, Jiang H, Kristman-Valente A, Neuenfeldt C, Rocz-de la Luz N, Sampson R, Suarez-Morales L, Wells E, Brigham G, Nunes E. Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatment. J Subst Abuse Treat. 2008 Oct; 35(3):304-11. PMID: 18294804; PMCID: PMC4897772.
      Citations:    
    81. Meier U, Ahmadi S, Killeen T, Al-Zain FT, Lemcke J, Meier U, Ahmadi S, Killeen T, Al-Zain FT, Lemcke J. Long-term outcomes following decompressive craniectomy for severe head injury. Acta Neurochir Suppl. 2008; 102:29-31. PMID: 19388283.
      Citations:    
    82. Stitzer ML, Petry N, Peirce J, Kirby K, Killeen T, Roll J, Hamilton J, Stabile PQ, Sterling R, Brown C, Kolodner K, Li R, Stitzer ML, Petry N, Peirce J, Kirby K, Killeen T, Roll J, Hamilton J, Stabile PQ, Sterling R, Brown C, Kolodner K, Li R. Effectiveness of abstinence-based incentives: interaction with intake stimulant test results. J Consult Clin Psychol. 2007 Oct; 75(5):805-11. PMID: 17907862.
      Citations:    
    83. Killeen T, Carter R, Copersino M, Petry N, Stitzer M, Killeen T, Carter R, Copersino M, Petry N, Stitzer M. Effectiveness of motivational incentives in stimulant abusing outpatients with different treatment histories. Am J Drug Alcohol Abuse. 2007; 33(1):129-37. PMID: 17366253.
      Citations:    
    84. Killeen TK, Killeen TK. Long acting injectable naltrexone is effective and safe for treating alcohol dependence. Evid Based Ment Health. 2005 Nov; 8(4):100. PMID: 16246876.
      Citations:    
    85. Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R, Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2005 Oct; 62(10):1148-56. PMID: 16203960.
      Citations:    
    86. Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF, Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF. Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res. 2004 Nov; 28(11):1710-7. PMID: 15547458.
      Citations:    
    87. Killeen TK, Brady KT, Gold PB, Tyson C, Simpson KN, Killeen TK, Brady KT, Gold PB, Tyson C, Simpson KN. Comparison of self-report versus agency records of service utilization in a community sample of individuals with alcohol use disorders. Drug Alcohol Depend. 2004 Feb 07; 73(2):141-7. PMID: 14725953.
      Citations: 30     Fields:    Translation:HumansCTClinical Trials
    88. McRae AL, Brady KT, Mellman TA, Sonne SC, Killeen TK, Timmerman MA, Bayles-Dazet W, McRae AL, Brady KT, Mellman TA, Sonne SC, Killeen TK, Timmerman MA, Bayles-Dazet W. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004; 19(3):190-6. PMID: 15129422.
      Citations:    
    89. Back SE, Sonne SC, Killeen T, Dansky BS, Brady KT, Back SE, Sonne SC, Killeen T, Dansky BS, Brady KT. Comparative profiles of women with PTSD and comorbid cocaine or alcohol dependence. Am J Drug Alcohol Abuse. 2003; 29(1):169-89. PMID: 12731687.
      Citations: 27     Fields:    Translation:Humans
    90. Killeen TK, Haight B, Brady K, Herman J, Michel Y, Stuart G, Young S, Killeen TK, Haight B, Brady K, Herman J, Michel Y, Stuart G, Young S. The effect of auricular acupuncture on psychophysiological measures of cocaine craving. Issues Ment Health Nurs. 2002 Jul-Aug; 23(5):445-59. PMID: 12079598.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    91. Killeen T, Brady KT, Killeen T, Brady KT. Parental stress and child behavioral outcomes following substance abuse residential treatment. Follow-up at 6 and 12 months. J Subst Abuse Treat. 2000 Jul; 19(1):23-9. PMID: 10867297.
      Citations: 9     Fields:    Translation:Humans
    92. Killeen TK, Brady KT, Killeen TK, Brady KT. Skin conductance hypo-responding in recently abstinent cocaine dependent inpatients. Am J Addict. 2000; 9(2):154-62. PMID: 10934577.
      Citations: 1     Fields:    Translation:Humans
    93. Brady KT, Killeen TK, Brewerton T, Lucerini S, Brady KT, Killeen TK, Brewerton T, Lucerini S. Comorbidity of psychiatric disorders and posttraumatic stress disorder. J Clin Psychiatry. 2000; 61 Suppl 7:22-32. PMID: 10795606.
      Citations: 205     Fields:    Translation:Humans
    94. Dansky BS, Brady KT, Saladin ME, Killeen T, Becker S, Roitzsch J, Dansky BS, Brady KT, Saladin ME, Killeen T, Becker S, Roitzsch J. Victimization and PTSD in individuals with substance use disorders: gender and racial differences. Am J Drug Alcohol Abuse. 1996 Feb; 22(1):75-93. PMID: 8651146.
      Citations: 18     Fields:    Translation:Humans
    95. Killeen TK, Brady KT, Thevos A, Killeen TK, Brady KT, Thevos A. Addiction severity, psychopathology and treatment compliance in cocaine-dependent mothers. J Addict Dis. 1995; 14(1):75-84. PMID: 7632749.
      Citations: 3     Fields:    Translation:Humans
    96. Brady KT, Killeen T, Jarrell P, Brady KT, Killeen T, Jarrell P. Depression in alcoholic schizophrenic patients. Am J Psychiatry. 1993 Aug; 150(8):1255-6. PMID: 8328573.
      Citations: 4     Fields:    Translation:Humans
    97. Killeen TK, Killeen TK. Alcoholism and liver transplantation: ethical and nursing implications. Perspect Psychiatr Care. 1993 Jan-Mar; 29(1):7-12. PMID: 8451166.
      Citations:    Fields:    Translation:Humans
    Killeen's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (254)
    Explore
    _
    Co-Authors (53)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _